Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Kluyvera cryocrescens

ABSTRACT: Whole genome sequencing of Kluyvera cryocrescens, an opportunistic pathogen

PROVIDER: PRJDB2772 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR015589_1.fastq.gz	Fastqsanger.gz
	DRR015589_2.fastq.gz	Fastqsanger.gz
	DRR015590_1.fastq.gz	Fastqsanger.gz
	DRR015590_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Project description:Whole genome sequencing of Kluyvera georgiana, an opportunistic pathogen

| PRJDB2484 | ENA

Project description:Whole genome sequencing of Kluyvera intermedia, an opportunistic pathogen

| PRJDB2018 | ENA

Kluyvera cryocrescens

Project description:Kluyvera cryocrescens overview

| PRJNA172237 | ENA

Kluyvera cryocrescens strain:K629

Project description:MDR Kluyvera cryocrescens whole genome sequence and assembly

| PRJNA930606 | ENA

Kluyvera cryocrescens strain:SCW13

Project description:Kluyvera cryocrescens SCW13 Genome sequencing and assembly

| PRJNA554456 | ENA

Project description:Kluyvera cryocrescens NBRC 102467 genome sequencing project

| PRJDB285 | ENA

Kluyvera cryocrescens strain:L2

Project description:Kluyvera cryocrescens strain:L2 Genome sequencing and assembly

| PRJNA259409 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Whole genome sequencing of Aeromonas media, an opportunistic pathogen

| PRJDB2240 | ENA

Project description:Whole genome sequencing of Clostridium histolyticum, an opportunistic pathogen

| PRJDB2661 | ENA